166 related articles for article (PubMed ID: 32987673)
21. PEG-PE/clay composite carriers for doxorubicin: Effect of composite structure on release, cell interaction and cytotoxicity.
Kohay H; Sarisozen C; Sawant R; Jhaveri A; Torchilin VP; Mishael YG
Acta Biomater; 2017 Jun; 55():443-454. PubMed ID: 28400314
[TBL] [Abstract][Full Text] [Related]
22. Clay particles destabilize engineered nanoparticles in aqueous environments.
Zhou D; Abdel-Fattah AI; Keller AA
Environ Sci Technol; 2012 Jul; 46(14):7520-6. PubMed ID: 22721423
[TBL] [Abstract][Full Text] [Related]
23. Removal of crude oil polycyclic aromatic hydrocarbons via organoclay-microbe-oil interactions.
Ugochukwu UC; Fialips CI
Chemosphere; 2017 May; 174():28-38. PubMed ID: 28157606
[TBL] [Abstract][Full Text] [Related]
24. Praziquantel systems with improved dissolution rate obtained by high pressure homogenization.
Gonzalez MA; Ramírez Rigo MV; Gonzalez Vidal NL
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():28-35. PubMed ID: 30274060
[TBL] [Abstract][Full Text] [Related]
25. Improvement of the in vitro dissolution of praziquantel by complexation with alpha-, beta- and gamma-cyclodextrins.
Becket G; Schep LJ; Tan MY
Int J Pharm; 1999 Mar; 179(1):65-71. PubMed ID: 10053203
[TBL] [Abstract][Full Text] [Related]
26. Adsorption of Salmonella enteritidis by cetylpyridinium-exchanged montmorillonite clays.
Herrera P; Burghardt RC; Phillips TD
Vet Microbiol; 2000 Jun; 74(3):259-72. PubMed ID: 10808094
[TBL] [Abstract][Full Text] [Related]
27. Clay-Polymer Nanocomposites Prepared by Reactive Melt Extrusion for Sustained Drug Release.
Liu X; Lu X; Su Y; Kun E; Zhang F
Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31936176
[No Abstract] [Full Text] [Related]
28. Metachromasy as an indicator of photostabilization of methylene blue adsorbed to clays and minerals.
Samuels M; Mor O; Rytwo G
J Photochem Photobiol B; 2013 Apr; 121():23-6. PubMed ID: 23474529
[TBL] [Abstract][Full Text] [Related]
29. Sepiolite Clay Attenuates the Development of Hypercholesterolemia and Obesity in Mice Fed a High-Fat High-Cholesterol Diet.
Gutman R; Rauch M; Neuman A; Khamaisi H; Jonas-Levi A; Konovalova Y; Rytwo G
J Med Food; 2020 Mar; 23(3):289-296. PubMed ID: 31580748
[TBL] [Abstract][Full Text] [Related]
30. The systems containing clays and clay minerals from modified drug release: a review.
Rodrigues LA; Figueiras A; Veiga F; de Freitas RM; Nunes LC; da Silva Filho EC; da Silva Leite CM
Colloids Surf B Biointerfaces; 2013 Mar; 103():642-51. PubMed ID: 23253474
[TBL] [Abstract][Full Text] [Related]
31. Adsorption of microcystin-LR onto kaolinite, illite and montmorillonite.
Liu YL; Walker HW; Lenhart JJ
Chemosphere; 2019 Apr; 220():696-705. PubMed ID: 30611067
[TBL] [Abstract][Full Text] [Related]
32. In vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatment.
de Souza AL; Andreani T; de Oliveira RN; Kiill CP; dos Santos FK; Allegretti SM; Chaud MV; Souto EB; Silva AM; Gremião MP
Int J Pharm; 2014 Mar; 463(1):31-7. PubMed ID: 24370839
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of melt granulation and ultrasonic spray congealing as techniques to enhance the dissolution of praziquantel.
Passerini N; Albertini B; Perissutti B; Rodriguez L
Int J Pharm; 2006 Aug; 318(1-2):92-102. PubMed ID: 16697539
[TBL] [Abstract][Full Text] [Related]
34. Dissolution dialysis studies of metronidazole-montmorillonite adsorbates.
Shrivastava R; Jain SR; Frank SG
J Pharm Sci; 1985 Feb; 74(2):214-6. PubMed ID: 3989696
[TBL] [Abstract][Full Text] [Related]
35. Theoretical and experimental study of a praziquantel and beta-cyclodextrin inclusion complex using molecular mechanic calculations and H1-nuclear magnetic resonance.
de Jesus MB; de Matos Alves Pinto L; Fraceto LF; Takahata Y; Lino AC; Jaime C; de Paula E
J Pharm Biomed Anal; 2006 Jun; 41(4):1428-32. PubMed ID: 16678375
[TBL] [Abstract][Full Text] [Related]
36. Hybrid systems based on "drug - in cyclodextrin - in nanoclays" for improving oxaprozin dissolution properties.
Mura P; Maestrelli F; Aguzzi C; Viseras C
Int J Pharm; 2016 Jul; 509(1-2):8-15. PubMed ID: 27188644
[TBL] [Abstract][Full Text] [Related]
37. Interactions of DNA with clay minerals and soil colloidal particles and protection against degradation by DNase.
Cai P; Huang QY; Zhang XW
Environ Sci Technol; 2006 May; 40(9):2971-6. PubMed ID: 16719099
[TBL] [Abstract][Full Text] [Related]
38. Transdermal evaporation delivery system of praziquantel for schistosomiasis japonicum chemotherapy.
Wang L; Zheng X; Fang Y; Wang Y; Duan C; Yao B
J Pharm Sci; 2011 Jul; 100(7):2769-77. PubMed ID: 21319162
[TBL] [Abstract][Full Text] [Related]
39. Combining Mechanochemistry and Spray Congealing for New Praziquantel Pediatric Formulations in Schistosomiasis Treatment.
Albertini B; Perissutti B; Bertoni S; Zanolla D; Franceschinis E; Voinovich D; Lombardo F; Keiser J; Passerini N
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30870971
[TBL] [Abstract][Full Text] [Related]
40. Nano-Clays for Cancer Therapy: State-of-the Art and Future Perspectives.
Persano F; Leporatti S
J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
